Geoffrey Hinton, a leading figure in AI research, is advocating for an FDA-style approval process for AI models, requiring companies to demonstrate safety before public release. This proposal is significant for the AI/ML community as it addresses growing concerns about potential risks and aligns with recent incidents like OpenAI’s decision to halt the release of a new model. The potential for rapid, recursive self-improvement in AI systems suggests that proactive regulatory measures may be needed within the next one to two years.
Read the full article at Business Insider
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



